NSAIDs for PI3K-altered head and neck cancer: a biomarker-driven therapeutic opportunity
{{output}}
Non-steroidal anti-inflammatory drugs (NSAIDs), primarily aspirin, have long been studied for their anti-cancer properties. Epidemiologic studies have reported diminished rates of several cancers in regular NSAID users. NSAIDs inhibit cyclooxygenase (COX) enzy... ...